Carregant...

Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine

BACKGROUND: 1-(4-isopropylphenyl)-β-carboline-3-carboxylic acid (ICCA) was modified by Trp-Phe-Phe to form 1-(4-isopropylphenyl)-β-carboline-3-carbonyl-Trp-Phe-Phe (ICCA-WFF). PURPOSE: The object of preparing ICCA-WFF was to enhance the in vivo efficacy of ICCA, to explore the possible targeting act...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Zhang, Xiaoyi, Zhang, Yixin, Wang, Yaonan, Wu, Jianhui, Chen, Haiyan, Zhao, Ming, Peng, Shiqi
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6982437/
https://ncbi.nlm.nih.gov/pubmed/32021191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S229856
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!